Livforsakringsbolaget Skandia, Omsesidigt Laboratory Corp Of America Holdings Transaction History

Livforsakringsbolaget Skandia, Omsesidigt

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$204.81 - $262.19 $102,405 - $131,095	-500 Reduced 76.69%	152 $31,000
Q2 2022 Aug 16, 2022	SELL	$213.86 - $277.87 $64,158 - $83,361	-300 Reduced 31.51%	652 $153,000
Q4 2021 Feb 14, 2022	SELL	$271.6 - $314.21 $190,120 - $219,947	-700 Reduced 42.37%	952 $299,000
Q3 2021 Oct 28, 2021	BUY	$274.82 - $308.34 $54,964 - $61,667	200 Added 13.77%	1,652 $465,000
Q4 2020 Mar 02, 2021	BUY	$186.91 - $214.42 $93,455 - $107,210	500 Added 52.52%	1,452 $296,000
Q4 2019 Jan 28, 2020	SELL	$163.48 - $173.61 $65,391 - $69,444	-400 Reduced 29.59%	952 $161,000
Q2 2019 Jul 19, 2019	BUY	$144.16 - $172.9 $57,664 - $69,160	400 Added 42.02%	1,352 $234,000
Q3 2018 Oct 26, 2018	SELL	$167.67 - $188.27 $100,601 - $112,962	-600 Reduced 38.66%	952 $165,000
Q4 2017 Jan 18, 2018	SELL	$147.99 - $163.95 $59,196 - $65,580	-400 Reduced 20.49%	1,552 $248,000
Q3 2017 Oct 12, 2017	BUY	$149.47 - $160.56 $291,765 - $313,413	1,952	1,952 $295,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Livforsakringsbolaget Skandia, Omsesidigt, based on Form 13F filings with the SEC.

Stay updated on Livforsakringsbolaget Skandia, Omsesidigt with notifications on news.